Therapeutic use for treating of leukemia
    32.
    发明授权
    Therapeutic use for treating of leukemia 失效
    治疗白血病的治疗用途

    公开(公告)号:US08236811B2

    公开(公告)日:2012-08-07

    申请号:US12485401

    申请日:2009-06-16

    CPC classification number: A61K31/519 A61K31/704 A61K31/7068 A61K2300/00

    Abstract: The disclosure relates to methods of treating leukaemia, in particular myeloid leukaemia, comprising administering the compound N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-N′-(1,1-dimethylethyl)-urea or a hydrate, a pharmaceutically acceptable salt or a solvate thereof.

    Abstract translation: 本公开涉及治疗白血病,特别是骨髓性白血病的方法,包括给予化合物N- [2-(2,1,3-苯并噻二唑-5-基氨基)-6-(2,6-二氯苯基)吡啶并[ 3-d]嘧啶-7-基] -N' - (1,1-二甲基乙基) - 脲或其水合物,其药学上可接受的盐或溶剂化物。

    Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof
    33.
    发明授权
    Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof 有权
    吡啶并嘧啶衍生物及其制备方法及其治疗用途

    公开(公告)号:US07893259B2

    公开(公告)日:2011-02-22

    申请号:US12415256

    申请日:2009-03-31

    CPC classification number: C07D471/04

    Abstract: The disclosure concerns pyrido[2,3-d]pyrimidine derivatives, their preparation and their therapeutic application, of general formula (I): and acid addition salts, hydrates and solvates thereof, as well as in the form of enantiomers, diastereoisomers and mixtures thereof. The disclosure also concerns methods for preparing said derivatives, pharmaceutical compositions containing a compound of general formula (I), and their therapeutic use.

    Abstract translation: 本公开涉及通式(I)的吡啶并[2,3-d]嘧啶衍生物及其制备方法及其治疗应用:及其酸加成盐,水合物和溶剂化物,以及对映异构体,非对映异构体和混合物的形式 其中。 本公开还涉及制备所述衍生物的方法,含有通式(I)的化合物的药物组合物及其治疗用途。

Patent Agency Ranking